LRPPRC promotes glycolysis by stabilising LDHA mRNA and its knockdown plus glutamine inhibitor induces synthetic lethality via m<sup>6</sup> A modification in triple-negative breast cancer.

Authors:
Yu Y; Deng H; Wang W; Xiao S; Zheng R and 4 more

Journal:
Clin Transl Med

Publication Year: 2024

DOI:
10.1002/ctm2.1583

PMCID:
PMC10875709

PMID:
38372449

Journal Information

Full Title: Clin Transl Med

Abbreviation: Clin Transl Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Biomedical Engineering

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CONFLICT OF INTEREST STATEMENT The authors declare they have no conflicts of interest."

Evidence found in paper:

"This study was supported by the National Natural Science Foundation of China (No. 82372844 to B.Z.) and the National Natural Science Foundation of China (No. 82303124 to W.W.W.)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025